Monitor for the actual definitive proxy statement (DEF14A) and any related SC 13D filings to understand the specific activist demands and board proposals. The cross-filing amplifier signals suggest elevated probability of a contested proxy fight, watch for dissident nominee slate and management response.
SNDX drugs
SNDX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 1 $19.11entry
- T+1 · 7mo ago +4.45%α +4.79% · $19.96
- T+5 · 6mo ago +7.48%α +5.14% · $20.54
- T+20 · 6mo ago −1.36%α −6.64% · $18.85
- T+60 · 4mo ago +2.72%α −0.35% · $19.63
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Syndax Pharmaceuticals filed a DEFA14A (additional definitive proxy soliciting materials) on April 30, 2026. The filing is a definitive additional proxy statement, but the actual document content is unavailable, only the SEC filing header and metadata are provided. The filing type suggests ongoing proxy solicitation activity, but without document text, no specific proposals, activist demands, or financial figures can be extracted.
Key Facts
- Filed DEFA14A on April 30, 2026
- Filed by Syndax Pharmaceuticals Inc (ticker: SNDX)
- Document content was not available for analysis
- Market cap: $1.8B with 95% analyst bullish consensus
- Cross-filing context indicates dissident proxy activity (activist context, DEF14A context, executive change context, preliminary context), all flagged as amplifiers
Financial Impact
No financial figures available from filing documents
Risk Factors
- Potential activist campaign could lead to board changes or strategic review
- Uncertainty due to lack of document content
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-197877 |
| Document: 0001193125-26-197877-index-headers.html | 0001193125-26-197877 |
| Document: 0001193125-26-197877-index.html | 0001193125-26-197877 |
| Document: 0001193125-26-197877.txt | 0001193125-26-197877 |
Track record
16 reports on SNDX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $9.45 Now $9.13 −3.39% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $9.49 Now $9.13 −3.79% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $9.49 Now $9.13 −3.79% settles Feb 8
- Nov 2, 202614d ago 8-K Neutral 5/10 No price data
- Nov 2, 202614d ago Press Release Neutral 2/10 No price data
- Nov 2, 202614d ago Press Release Neutral 5/10 Entry $14.29 Now $9.13 −36.11% settles Feb 1
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $13.65 Now $9.13 −33.11% settles Jan 28
- Jul 14, 202617w ago 8-K Bullish 7/10 Entry $24.13 to $17.03 Now $9.13 −62.16% ▼ −29.42% −32.80% vs SPY
- Jul 1, 202619w ago Press Release Neutral 2/10 Entry $21.82 to $18.20 Now $9.13 −58.16% ▼ −16.59% −20.16% vs SPY
- Jun 11, 202622w ago Press Release Bullish 7/10 Entry $17.91 to $20.56 Now $9.13 −49.02% ▲ +14.80% +10.40% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers